Lipoprotein(a) levels are genetically determined and, when elevated, are a risk factor for cardiovascular disease and aortic stenosis. There are no approved pharmacologic therapies to lower ...

A growing body of research has harnessed the innate properties of lipoproteins as biocompatible nanocarriers for targeted cancer therapy. Lipoproteins such as high-density and low-density particles ...

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...

Lipoprotein (a) is a low-density lipoprotein that transports cholesterol in the blood. The lipoprotein (a) test — or Lp(a) test — determines the level of this lipoprotein in the blood, and its results ...

Lipoproteins consist of lipids that are chemically attached to protein conjugates called apolipoproteins. These amphipathic molecules have a central lipid core of cholesterol esters and ...

New research has shown that the blood vessels that feed aggressive brain tumors have receptors that could allow a new type of drug-containing nanoparticle to be used to starve the tumors of the energy ...

Lipoprotein(a) appears tied to the risk of major adverse cardiac events, MI, and peripheral artery disease in both primary and secondary prevention populations independent of baseline high-sensitivity ...

Researchers at Curtin University in Perth, Australia, have discovered that leakage from blood into the brain of fat-carrying particles transporting toxic proteins are a possible cause of Alzheimer's ...

Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — In this video, Christine Curcio, PhD, FARVO, discusses notable developments presented at the ...

A new computer program is helping genomic researchers to make sense of the reams of data—a massive collection of numbers and decimals—that result from using DNA microarrays, the widespread method of ...